Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Incorporating novel treatment insights for ER+ early BC patients

CDK4/6 inhibitors for early breast cancer: State-of-the-art

Date

15 Sep 2024

Session

Incorporating novel treatment insights for ER+ early BC patients

Topics

Endocrine Therapy;  Targeted Therapy

Tumour Site

Breast Cancer

Presenters

Stephen Johnston

Authors

S.R.D. Johnston

Author affiliations

  • Breast Unit, The Royal Marsden Hospital (Chelsea) - NHS Foundation Trust, SW3 6JJ - London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Incorporating novel treatment insights for ER+ early BC patients

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.